Feb 03, 2020 - Medtronic's (MDT) next generation BlueSync-enabled implantable heart devices, which incorporate upgraded features, receive CE mark.
Jan 28, 2020 - A series of product launches despite the ongoing regulatory hurdles is likely to favor revenues in the medical products space this earnings season.
Jan 27, 2020 - Quest Diagnostics (DGX) is currently concentrating on diagnostic information services arm and disciplined capital deployment.
Jan 23, 2020 - With respect to Intersect ENT's (XENT) Propel line, the PROPEL suite scores as the standard of care for polyp patients undergoing sinus surgery.
Jan 22, 2020 - Medtronic's (MDT) Micra AV cleared by the FDA for the treatment of AV block in patients eligible for pacemaker implantation.
Jan 21, 2020 - Hill-Rom (HRC) is optimistic about its latest buyouts of Breathe Technologies and Voalte, mirroring its outstanding capital management strategy in turn.
Jan 20, 2020 - Cardiovascular Systems (CSII) is optimistic about maintaining its growth momentum on several recent developments.
Jan 20, 2020 - Medtronic (MDT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Jan 17, 2020 - Boston Scientific's (BSX) recent takeovers of BTG, NxThera, Claret Medical, VENITI and Augmenix make us optimistic about their positive synergies to be added to the company portfolio.
Jan 16, 2020 - Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.